Drawing for PANTHEON

USPTO serial 99562954

PANTHEON

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
IP, KENNINA NGA-YU
Law office
TMO LAW OFFICE 121

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with PANTHEON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RYAN S. HILBERT

RYAN S. HILBERT HOLLEY & MENKER PAPO Box 331937Atlantic Beach, FL 32233United States

Goods and services

ClassDescriptionStatusFirst use
005Gene therapy pharmaceutical preparations; Pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; Biological preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations and gene therapy products in the nature of biological preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disordersACTIVE—
042Biotechnology research; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of biochemical, therapeutic, and pharmaceutical preparations; Research and development of biological computers for designing, developing, testing and manufacturing therapies for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Scientific and technological consultation services in the field of designing, developing, testing and manufacturing biochemical, therapeutic, and pharmaceutical preparations; Scientific and technological consultation services in the field of designing, developing, testing and manufacturing therapies for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Custom development of therapies and pharmaceutical and biopharmaceutical products; Pharmaceutical research for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Providing medical and scientific research information; Consulting services in the field of genetic scienceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 3, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 3, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 4, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2026DOCKASSIGNED TO EXAMINER—
Dec 23, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 23, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 23, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance